1. Antiarthritic properties and unique pharmacologic profile of a potential chrysotherapeutic agent: SK&F D-39162;Walz;J Pharmacol Exp Therap,1976
2. Auranofin: an oral chrysotherapeutic agent for the treatment of rheumatoid arthritis;Berglof;J Rheumatol,1978
3. Auranofin: new oral gold compound for the treatment of rheumatoid arthritis;Finkelstein;Ann Rheum Dis,1976
4. Effects of gold compounds on the function of phagocytic cells. I. Supression of phagocytosis and the generation of chemiluminescence by polymorphonuclear leukocytes;Davis;J Rheumatol,1982
5. Inhibition of lysosomal enzyme release from rat leukocytes by auranofin. A new chrysotherapeutic agent;Dimartino;Inflammation,1977